These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 26996299)

  • 1. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
    Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma.
    Li K; Zhao G; Ao J; Gong D; Zhang J; Chen Y; Li J; Huang L; Xiang R; Hu J; Lin P; Wei Y
    Cancer Lett; 2019 Feb; 442():271-278. PubMed ID: 30439540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
    Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.
    Feng MX; Ma MZ; Fu Y; Li J; Wang T; Xue F; Zhang JJ; Qin WX; Gu JR; Zhang ZG; Xia Q
    Mol Cancer; 2014 Oct; 13():226. PubMed ID: 25273699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma.
    Li XL; Liu L; Li DD; He YP; Guo LH; Sun LP; Liu LN; Xu HX; Zhang XP
    Sci Rep; 2017 Jan; 7():40464. PubMed ID: 28084395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4.
    Shi WK; Shang QL; Zhao YF
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35293598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D; Zhao W; Feng Y; Liu J
    Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
    Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
    Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.
    Zhang X; Cheng SL; Bian K; Wang L; Zhang X; Yan B; Jia LT; Zhao J; Gammoh N; Yang AG; Zhang R
    Oncotarget; 2015 Feb; 6(4):2277-89. PubMed ID: 25537511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
    Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
    Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H
    Cancer Lett; 2017 Sep; 403():260-270. PubMed ID: 28649002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
    Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
    Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
    Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
    Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth.
    Zhu JF; Liu Y; Huang H; Shan L; Han ZG; Liu JY; Li YL; Dong X; Zeng W
    Cancer Cell Int; 2018; 18():193. PubMed ID: 30479571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
    Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
    Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.